-+ 0.00%
-+ 0.00%
-+ 0.00%

LivaNova Highlights CORE-VNS Study Showing VNS Therapy Reduces Seizure Frequency and Healthcare Costs in Drug-Resistant Epilepsy

Reuters·12/03/2025 14:01:10

Please log in to view news